Abstract
Purpose
The purpose of this study is to validate a folate-receptor (FR)-targeted dendrimer, PEG-G3-(Gd-DTPA)11-(folate)5, for its ability to detect FR-positive tumors, by using dynamic contrast-enhanced MRI.
Procedures
KB cells, FR siRNA knockdown KB cells, and FR negative HT-1080 cells, were incubated with fluorescein-labeled dendrimer and their cellular uptake was observed. Dynamic contrast-enhanced MRI was performed on mice-bearing KB and HT-1080 tumors and the enhancement patterns and parameters were analyzed.
Results
Green fluorescence was found in the KB cells in the cellular uptake experiment, but was not seen in other settings. In the dynamic contrast-enhanced MRI, the 30-min washout percentage was −4 ± 18% in the KB tumors and 39 ± 23% in the HT-1080 tumors. A 17% cut-off point gave a sensitivity of 94.4% and a specificity of 93.8%.
Conclusions
We have demonstrated the targeting ability of PEG-G3-(Gd-DTPA)11-(folate)5 in vitro and in vivo. A 17% cut-off point for a 30-min washout percentage can be a useful parameter for the diagnosis of FR-positive tumors.
Similar content being viewed by others
References
Campbell IG, Jones TA, Foulkes WD, Trowsdale J (1991) Folate-binding protein is a marker for ovarian cancer. Cancer Res 51:5329–5338
Wu M, Gunning W, Ratnam M (1999) Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Cancer Epidemiol Biomarkers Prev 8:775–782
Iwakiri S, Sonobe M, Nagai S et al (2008) Expression status of folate receptor alpha is significantly correlated with prognosis in non-small-cell lung cancers. Ann Surg Oncol 15:889–899
Parker N, Turk MJ, Westrick E et al (2005) Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 338:284–293
Antony AC (1992) The biological chemistry of folate receptors. Blood 79:2807–2820
Lee RJ, Low PS (1994) Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem 269:3198–3204
Mathias CJ, Wang S, Lee RJ et al (1996) Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J Nucl Med 37:1003–1008
Leamon CP, Low PS (2001) Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov Today 6:44–51
McHugh M, Cheng YC (1979) Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells. J Biol Chem 254:11312–11318
Hu XF, Xing PX (2003) Discovery and validation of new molecular targets for ovarian cancer. Curr Opin Mol Ther 5:625–630
Bettio A, Honer M, Muller C et al (2006) Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors. J Nucl Med 47:1153–1160
Saborowski O, Simon GH, Raatschen HJ et al (2007) MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent. Contrast Media Mol Imaging 2:72–81
Sun C, Sze R, Zhang M (2006) Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J Biomed Mater Res A 78:550–557
Swanson SD, Kukowska-Latallo JF, Patri AK et al (2008) Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement. Int J Nanomedicine 3:201–210
Konda SD, Aref M, Wang S, Brechbiel M, Wiener EC (2001) Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. MAGMA 12:104–113
Artemov D, Mori N, Ravi R, Bhujwalla ZM (2003) Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res 63:2723–2727
Towner RA, Smith N, Doblas S et al (2008) In vivo detection of c-Met expression in a rat C6 glioma model. J Cell Mol Med 12:174–186
Chen TJ, Cheng TH, Hung YC et al (2008) Targeted folic acid-PEG nanoparticles for noninvasive imaging of folate receptor by MRI. J Biomed Mater Res A 87:165–175
Kawashima H, Matsui O, Suzuki M et al (2000) Breast cancer in dense breast: detection with contrast-enhanced dynamic MR imaging. J Magn Reson Imaging 11:233–243
Muramoto S, Uematsu H, Kimura H et al (2002) Differentiation of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging. Eur J Radiol 44:52–58
Ihre H, Padilla De Jesus OL, Frechet JM (2001) Fast and convenient divergent synthesis of aliphatic ester dendrimers by anhydride coupling. J Am Chem Soc 123:5908–5917
Chen WT, Shih TT, Chen RC et al (2002) Blood perfusion of vertebral lesions evaluated with gadolinium-enhanced dynamic MRI: in comparison with compression fracture and metastasis. J Magn Reson Imaging 15:308–314
Holm J, Hansen SI, Hoier-Madsen M, Birn H, Helkjaer PE (1999) High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity. Arch Biochem Biophys 366:183–191
Leamon CP, Reddy JA (2004) Folate-targeted chemotherapy. Adv Drug Deliv Rev 56:1127–1141
Wang S, Low PS (1998) Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J Control Release 53:39–48
Beduneau A, Ma Z, Grotepas CB et al (2009) Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles. PLoS ONE 4:e4343
Glunde K, Bhujwalla ZM (2008) Will magnetic resonance imaging (MRI)-based contrast agents for molecular receptor imaging make their way into the clinic? J Cell Mol Med 12:187–188
Brasch RC (1991) Rationale and applications for macromolecular Gd-based contrast agents. Magn Reson Med 22:282–287 discussion 300-283
Zhou XL, Zhi; Tang, Dazong; Xia, Liming; Meng, Liping; Xiang, Guangya. (2007) Preparation of targeted Gd3+ contrast agent based on folate—receptor and its relaxation. Zhongguo Yaoxue Zazhi 42:1640–1644
Yuan Z, Liu SY, Xiao XS, Zhong GR, Jiang QJ (2007) Folate-poly-l-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery. Zhonghua Yi Xue Za Zhi 87:673–678
Bathke W (1967) On intravenous injections into the retrobulbar venous plexus of white mice in bacteriological studies. Z Med Labortech 8:318–321
Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219:316–333
Acknowledgments
This research was supported in part by National Science Council grants 95-2314-B-532-005 and 96-2321-B-532-0001. We thank Mr. Hsiau Yu Yo and Mr. Wei Ju Hsu for their diligent laboratory work.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Supplementary figure 1
Immunoperoxidase KB cell staining for the folate receptor. Positive immunoreactions appeared as dark brown staining on the KB cell surfaces. Magnification, ×400. (JPG 101 KB)
Supplementary figure 2
The 1H NMR spectrum of the PEG-bis[G-3]-(OH)8. The spikes of G1and G2 methyl protons merged together at δ 1.61. However, the intensity ratio of the merged spike and the singlet of G3 methyl protons was 3:4 [(a + b):c = (1 + 2):4]. (GIF 182 KB)
Rights and permissions
About this article
Cite this article
Chen, WT., Thirumalai, D., Shih, T.TF. et al. Dynamic Contrast-Enhanced Folate-Receptor-Targeted MR Imaging Using a Gd-loaded PEG-Dendrimer–Folate Conjugate in a Mouse Xenograft Tumor Model. Mol Imaging Biol 12, 145–154 (2010). https://doi.org/10.1007/s11307-009-0248-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-009-0248-6